The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

The U.S. Department of Health and Human Services announced it will award $590 million to Moderna to accelerate the ...

MRNA intends to use the funds to support the development of its mRNA-based bird flu shot and expand clinical studies for ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...